trial · primary record
31-valent pneumococcal conjugate vaccine
Pneumococcal Disease
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 1390 |
| Primary completion | 2027-03 |
| Primary endpoint | For each of the 32 serotypes (the 31 serotypes included in VAX-31, and serotype 20B), the ratio (co-administration group to sequential administration group) of opsonophagocytic activity (OPA) geometric mean titers (GMT) in evaluable participants |
| Registry ID | NCT07365826 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:15.688Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07365826
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.